1. Clinical pharmacology of melatonin in the treatment of tinnitus: a review

   • Marco Miroddi
   • Rocco Bruno
   • Gioacchino Calapai

   Review Article 20 January 2015 Pages: 263 - 270

2. Two-stage designs in bioequivalence trials

   • Helmut Schütz

   Review Article 22 January 2015 Pages: 271 - 281

   

3. Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age

   • Ingvild Odsbu
   • Svetlana Skurtveit
   • Marte Handal

   Pharmacodynamics 30 December 2014 Pages: 283 - 291

4. Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia

   • Hui He
   • Jiye Yin
   • Zhaoqian Liu

   Pharmacogenetics 09 January 2015 Pages: 293 - 302

   

5. Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy

   • Ellen G. J. Hulskotte
   • R. Douglas Bruce
   • Joan R. Butterton

   Pharmacokinetics and Disposition 11 February 2015 Pages: 303 - 311

   

6. A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells—using rifampicin as an example

   • Oskar Clewe
   • Sylvain Goutelle
   • Ulrika S. H. Simonsson

   Pharmacokinetics and Disposition Open access 27 January 2015 Pages: 313 - 319

   

7. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol

   • Tuukka Saarikoski
   • Teijo I. Saari
   • Kari Laine

   Pharmacokinetics and Disposition 06 January 2015 Pages: 321 - 327

   

8. Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

   • Bruce K. Birmingham
   • Sarah R. Bujac
   • Helen J. Ambrose

   Pharmacokinetics and Disposition 30 January 2015 Pages: 329 - 340

   

9. Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

   • Bruce K. Birmingham
   • Sarah R. Bujac
   • Helen J. Ambrose

   Pharmacokinetics and Disposition 12 February 2015 Pages: 341 - 355

   

10. Baclofen overdose treated with continuous venovenous hemofiltration

    • Didier Meulendijks
    • Saheed Khan
    • Jos H. Beijnen

    Pharmacokinetics and Disposition 09 January 2015 Pages: 357 - 361

    

11. Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients

    • Björn Belfrage
    • Anders Koldestam
    • Susanna M. Wallerstedt

    Pharmacoepidemiology and Prescription Open access 09 January 2015 Pages: 363 - 368

    

12. Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study

    • Raymond Noordam
    • Nikkie Aarts
    • Loes E. Visser

    Pharmacoepidemiology and Prescription 06 January 2015 Pages: 369 - 375

    

13. Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF)

    • Deirdre M. D’Arcy
    • Owen I. Corrigan
    • Maria B. Donnelly

    Letter to the Editors 26 November 2014 Pages: 377 - 378

    

14. QT prolongation induced by hydroxyzine: a pharmacovigilance case report

    • Jonathan Vigne
    • Joachim Alexandre
    • Antoine Coquerel

    Letter to the Editors 28 January 2015 Pages: 379 - 381

    

15. Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring

    • Cristina Gervasoni
    • Roberta Terzi
    • Dario Cattaneo

    Letter to the Editors 22 January 2015 Pages: 383 - 385

    

16. Erratum to: Flupirtine-induced liver injury—Seven cases from the Berlin Case–control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database

    • Antonios Douros
    • Elisabeth Bronder
    • Edeltraut Garbe

    Erratum 22 January 2015 Pages: 387 - 387